Abstract 12895: Superior Effectiveness and Safety of Ticagrelor in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Nationwide Registry-Based Study

Sissel Johanne Godtfredsen,Manan Pareek,Peter Derek Christian Leutscher,Steen Hylgaard Jørgensen,Jawad H. Butt,Gunnar Gislason,Lars Køber,Emil L. Fosbøl,Deepak L. Bhatt,Christian Torp-Pedersen,Kristian Kragholm

Abstract 12895: Superior Effectiveness and Safety of Ticagrelor in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Nationwide Registry-Based Study

2021

Sissel Johanne Godtfredsen
Manan Pareek
Peter Derek Christian Leutscher
Steen Hylgaard Jørgensen
Jawad H. Butt
Gunnar Gislason
Lars Køber
Emil L. Fosbøl
Deepak L. Bhatt
Christian Torp-Pedersen
Kristian Kragholm

Introduction: Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is recommended following PCI for ACS. The optimal choice of P2Y12 inhibitor remains debated. We compared effectiveness and...

Keywords:

Percutaneous coronary intervention
Cardiology
Ticagrelor
Acute coronary syndrome
Aspirin
Conventional PCI
P2Y12
Internal medicine
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations